Covered professional services is defined at 414.1305, with reference to the statutory definition at section 1848(k)(3) of the Act, as services for which payment is made under, or based on, the PFS and which are furnished by an eligible clinician (physician
Sometimes I sleep with tobacco in my mouth
Based on further review, CMS has observed that a number of NDC-9s of Part D rebatable drugs approved on or before October 1, 2021, do not have AMP reported in the period of January 1, 2021, through September 30, 2021, and a number of NDC-9s of subsequently approved drugs do not have AMP reported in the first calendar year beginning after the drug's first marketed date
To understand the potential health equity impacts of a new ambulatory specialty model and to help ensure the goals laid out in the CMS Strategic Plan and the Innovation Center Strategy Refresh are met, we request feedback on the following questions: (29) Similar to how other Innovation Center models may offer financial and technical supports to certain qualifying clinicians (for example, safety net clinicians) as part of a model's health equity strategy (for example, the GUIDE model [619] ), how might CMS support the participation of clinicians in an ambulatory specialty model that may serve a higher proportion of underserved patients (for example, small practices or clinicians in rural areas)
(4) Promoting Interoperability Performance Category in MVPs In the CY 2022 PFS final rule, we finalized at 414.1365(c)(4)(i) that an MVP Participant is required to meet the Promoting Interoperability performance category's reporting requirements
